...
首页> 外文期刊>American Journal of Pathology >Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma
【24h】

Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma

机译:AP-1转录活性的抑制阻止小鼠骨肉瘤的迁移,侵袭和实验转移。

获取原文
获取原文并翻译 | 示例
           

摘要

A well-characterized murine osteosarcoma model for metastasis and invasion was used in this study to determine the role of AP-1 in the progression of this disease. We analyzed K12 and K7M2 cells, two clonally related murine osteosarcoma cell lines that have been characterized as low metastatic or high metastatic, respectively, for AP-1 components and activity. AP-1 DNA binding was similar between the two cell lines; however AP-1 transcriptional activity was enhanced by 3- to 5-fold in K7M2 cells relative to that in K12 cells. The AP-1 complexes in K12 and K7M2 cells was composed primarily of cJun, JunD, FosB, Fra1, and Fra2, with the contribution of individual components in the complex varying between the two cell lines. In addition, an increase in phosphorylated cJun, JNK activity, and phosphorylated ERK1/2 was associated with the more metastatic osteosarcoma phenotype. The significance of AP-1 activation was confirmed by conditional expression of TAM67, a dominant negative mutant of cJun. Under conditions where TAM67 inhibited AP-1 activity in K7M2 cells, migration and invasion potential was significantly blocked. Tam67 expression in aggressive osteosarcoma cells decreased long-term in vivo experimental metastasis and increased survival of mice. This study shows that differences in metastatic activity can be due to AP-1 activation. The inhibition of AP-1 activity may serve as a therapeutic tool in the management of osteosarcoma.
机译:本研究使用特征明确的小鼠骨肉瘤转移 和侵袭模型,确定 AP-1在该疾病进展中的作用。我们分析了K12和 K7M2细胞,这两种克隆相关的鼠类骨肉瘤细胞系 分别被表征为低转移或高转移, -1组成和活动。两种细胞系之间的AP-1 DNA结合 类似。然而,相对于 而言,AP-1转录活性在K7M2细胞中提高了3到5倍。 K12和K7M2细胞 中的AP-1复合物主要由cJun,JunD,FosB,Fra1和Fra2, 组成,复合物中的各个成分均起作用> 在两个细胞系之间变化。此外,磷酸化的cJun,JNK活性和磷酸化的ERK1 / 2 的增加 与转移性骨肉瘤表型有关。 TAM67是cJun的显性负突变体,其条件性表达证实了AP-1的激活。在TAM67抑制K7M2细胞中AP-1活性的条件下, 迁移和侵袭潜能被显着抑制。 Tam67在侵袭性骨肉瘤细胞中的表达下降< sup> 小鼠的长期体内实验转移和存活率的提高。这项研究表明,转移活性的差异 可能归因于AP-1的激活。抑制AP-1活性 可以作为治疗骨肉瘤的治疗工具。

著录项

  • 来源
    《American Journal of Pathology》 |2009年第1期|265-275|共11页
  • 作者单位

    From the Cell and Cancer Biology Department,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland|Division of Medical Biochemistry,Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa;

    From the Cell and Cancer Biology Department,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

    From the Cell and Cancer Biology Department,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

    From the Cell and Cancer Biology Department,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

    and the Pediatric Oncology Branch,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

    Division of Medical Biochemistry,Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa;

    From the Cell and Cancer Biology Department,Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号